These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Graves' disease presenting as elephantiasic pretibial myxedema and nodules of the hands. Cho S; Choi JH; Sung KJ; Moon KC; Koh JK Int J Dermatol; 2001 Apr; 40(4):276-7. PubMed ID: 11454085 [TBL] [Abstract][Full Text] [Related]
10. Patient with monoclonal gammopathy, thyrotoxicosis, pretibial myxedema and thyroid-associated ophthalmopathy; demonstration of direct binding of autoantibodies to the thyrotropin receptor. Tonacchera M; Costagliola S; Cetani F; Ducobu J; Stordeur P; Vassart G; Ludgate M Eur J Endocrinol; 1996 Jan; 134(1):97-103. PubMed ID: 8590966 [TBL] [Abstract][Full Text] [Related]
11. TSH and TSH receptor antibody-binding sites in fibroblasts of pretibial myxedema are related to the extracellular domain of entire TSH receptor. Chang TC; Wu SL; Hsiao YL; Kuo ST; Chien LF; Kuo YF; Change CC; Chang TJ Clin Immunol Immunopathol; 1994 Apr; 71(1):113-20. PubMed ID: 8137554 [TBL] [Abstract][Full Text] [Related]
12. Pretibial myxedema in a euthyroid patient: a case report. Ambachew R; Yosef T; Gebremariam AM; Demere L; Aberra T; Tarekegn G; Reja A Thyroid Res; 2021 Mar; 14(1):4. PubMed ID: 33648506 [TBL] [Abstract][Full Text] [Related]
13. Clinical Experience with Rituximab and Intravenous Immunoglobulin for Pretibial Myxedema: A Case Series. Kotwal A; Turcu AF; Sonawane V; Bahn RS; Pittelkow MR; Bridges A; Stan MN Thyroid; 2019 May; 29(5):692-699. PubMed ID: 30854936 [No Abstract] [Full Text] [Related]
14. Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy. Daumerie C; Ludgate M; Costagliola S; Many MC Eur J Endocrinol; 2002 Jan; 146(1):35-8. PubMed ID: 11751064 [TBL] [Abstract][Full Text] [Related]
15. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema. Stadlmayr W; Spitzweg C; Bichlmair AM; Heufelder AE Thyroid; 1997 Feb; 7(1):3-12. PubMed ID: 9086563 [TBL] [Abstract][Full Text] [Related]
16. Treatment of pretibial myxedema (PTM) with topical steroid ointment application with sealing cover (steroid occlusive dressing technique: steroid ODT) in Graves' patients. Takasu N; Higa H; Kinjou Y Intern Med; 2010; 49(7):665-9. PubMed ID: 20371956 [TBL] [Abstract][Full Text] [Related]
17. Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease. Rapoport B; Alsabeh R; Aftergood D; McLachlan SM Thyroid; 2000 Aug; 10(8):685-92. PubMed ID: 11014313 [TBL] [Abstract][Full Text] [Related]
18. Pretibial myxedema without ophthalmopathy: an initial presentation of Graves' disease. Lohiya S; Lohiya V; Stahl EJ Am J Med Sci; 2013 Jul; 346(1):73-5. PubMed ID: 23514670 [TBL] [Abstract][Full Text] [Related]
19. Local immune microenvironment of skin may play an important role in the development of pretibial myxedema. Chen X; Dong J; Zhang L; Zhao X; Shi R; Pan M; Zheng J Exp Dermatol; 2021 Dec; 30(12):1820-1824. PubMed ID: 34047397 [TBL] [Abstract][Full Text] [Related]
20. Elephantiasic pretibial myxedema: a novel treatment for an uncommon disorder. Susser WS; Heermans AG; Chapman MS; Baughman RD J Am Acad Dermatol; 2002 May; 46(5):723-6. PubMed ID: 12004314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]